| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9377475 | Biological Psychiatry | 2005 | 5 Pages |
Abstract
Venlafaxine and SSRI-induced PLM are likely to be the result of enhanced serotonergic availability and secondarily decreased dopaminergic effects. The results of this study might assist in the selection of antidepressants, especially in patients with pronounced sleep complaints.
Related Topics
Life Sciences
Neuroscience
Biological Psychiatry
Authors
Changkook Yang, David P. White, John W. Winkelman,